Table 2.
SNP genotype distribution and association with breast cancer risk. Analysis restricted to mutation carriers of European ancestry
Mutation | Genotype | Unaffected, N (%) | Affecteda, N (%) | HR | 95% CI | P value |
---|---|---|---|---|---|---|
BRCA1 | GG | 1,941 (71.3) | 2,160 (71.5) | 1 | ||
AG | 701 (25.8) | 775 (25.7) | 1.02 | 0.91–1.14 | ||
AA | 79 (2.9) | 85 (2.8) | 1.06 | 0.79–1.41 | ||
2-df test | 0.90 | |||||
Per-allele | 1.02 | 0.93–1.12 | 0.66 | |||
BRCA2 | GG | 909 (61.1) | 1,201 (64.9) | 1 | ||
AG | 504 (33.9) | 589 (31.8) | 0.96 | 0.83–1.10 | ||
AA | 76 (5.1) | 60 (3.2) | 0.75 | 0.53–1.05 | ||
2-df test | 0.24 | |||||
Per-allele | 0.92 | 0.82–1.04 | 0.17 |
Breast cancer